Pacific Ridge Capital Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-29,230
Closed -$704K 140
2017
Q2
$704K Sell
29,230
-620
-2% -$15.8K 0.21% 121
2017
Q1
$834K Buy
29,850
+6,880
+30% +$180K 0.24% 124
2016
Q4
$561K Buy
22,970
+430
+2% +$9.86K 0.2% 127
2016
Q3
$568K Sell
22,540
-130
-0.6% -$3.11K 0.23% 115
2016
Q2
$468K Hold
22,670
0.21% 124
2016
Q1
$455K Buy
22,670
+5,200
+30% +$99.7K 0.2% 127
2015
Q4
$353K Hold
17,470
0.16% 138
2015
Q3
$405K Sell
17,470
-2,484
-12% -$63.4K 0.2% 128
2015
Q2
$514K Sell
19,954
-2,382
-11% -$67.6K 0.21% 130
2015
Q1
$740K Buy
22,336
+460
+2% +$14.9K 0.29% 104
2014
Q4
$664K Buy
21,876
+2,790
+15% +$76.9K 0.28% 108
2014
Q3
$464K Buy
19,086
+6,676
+54% +$185K 0.24% 126
2014
Q2
$356K Sell
12,410
-60
-0.5% -$1.74K 0.24% 120
2014
Q1
$348K Sell
12,470
-140
-1% -$3.85K 0.24% 127
2013
Q4
$330K Buy
+12,610
New +$325K 0.22% 126

Other funds holding SBRA

Pacific Ridge Capital Partners's SBRA Position: Q3 2017 in Review

Pacific Ridge Capital Partners sold out of Sabra Healthcare REIT (SBRA) in Q3 2017, closing a stake of 29,230 shares — an estimated $704K sold.

Pacific Ridge Capital Partners first reported a position in SBRA in Q4 2013 and held it in 15 quarters. The position peaked at $834K in Q1 2017. 337 funds tracked by Wall St. Rank hold SBRA as of Q3 2017.

  • Pacific Ridge Capital Partners reported no remaining Sabra Healthcare REIT position as of Q3 2017 after selling out during the quarter.
  • Pacific Ridge Capital Partners sold 29,230 Sabra Healthcare REIT shares in Q3 2017, an estimated $704K.
  • Pacific Ridge Capital Partners first reported a position in Sabra Healthcare REIT in Q4 2013 and held it in 15 quarters.
  • Pacific Ridge Capital Partners's Sabra Healthcare REIT position peaked at $834K in Q1 2017.
  • 337 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2017.

Based on Pacific Ridge Capital Partners's 13F filing for Q3 2017, filed 13 Nov 2017.